Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo

Photodermatology Photoimmunology and Photomedicine

Volumn 20, Issue 5, 2004, Pages 248-251

  Kullavanijaya, Prisana ^a   Lim, Henry W ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Calcipotriene; Narrowband UVB; Vitiligo

Indexed keywords

CALCIPOTRIOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; OINTMENT; PHOTOTHERAPY; PRIORITY JOURNAL; RECURRENT DISEASE; SIDE EFFECT; SKIN PIGMENTATION; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION; VITILIGO;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; CALCITRIOL; COMBINED MODALITY THERAPY; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; OINTMENTS; RADIOTHERAPY DOSAGE; SKIN PIGMENTATION; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VITILIGO;

EID: 5444273608     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2004.00114.x     Document Type: Article

References (19)

1. Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PMM. Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch Dermatol 1998; 134: 1532-1540.
2. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997; 133: 1525-1528.
3. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well tolerated treatment for vitiligo. J Am Acad Dermatol 2001; 44: 99-1003.
4. Takahashi H, Ibe M, Kinouchi M, Ishida-Yamamoto A, Hashimoto Y, Iizuka H. Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation. J Dermatol Sci 2003; 31: 21-28.
5. 3. In: Wolverton SE, ed. Comprehensive dermatologic drug therapy. Philadelphia: WB Saunders Co, 2001; 685-694.
6. Schallreuter-Wood KU, Pittelkow MR, Swanson NN. Defective calcium transport in vitiliginous melanocytes. Arch Dermatol Res 1996; 288: 11-13.
7. Milde P, Hauser U, Simon T, et al. Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin. J Invest Dermatol 1991; 97: 230-239.
8. Ranson M, Posen S, Mason RS. Human melanocytes as a target tissue for hormones: in vitro studies with 1 alpha-25, dihydroxyvitamin D3, alpha-melanocyte stimulating hormone, and beta-estradiol. J Invest Dermatol 1988; 91: 593-598.
9. Schallreuter KU, Behrens-Williams S, Khaliq TP, et al. Increased epidermal functioning wild-type p53 expression in vitiligo. Exp Dermatol 2003; 12: 268-277.
10. Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology 1998; 197: 167-170.
11. Parsad D, Saini R, Nagpal R. Calcipotriol in vitiligo: a preliminary study. Pediatr Dermatol 1999; 16: 317-320.
12. Yalcin B, Sahin S, Bukulmez G, et al. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study. J Am Acad Dermatol 2001; 44: 634-637.
13. Ermis O, Alpsoy E, Cetin L, Yilmaz E. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. Br J Dermatol 2001; 145: 472-475.
14. Ameen M, Exarchou V, Chu AC. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Br J Dermatol 2001; 145: 476-479.
15. Chiaverini C, Passeron T, Ortonne JP. Treatment of vitiligo by topical calcipotriol. J Eur Acad Dermatol Venereol 2002; 16: 137-138.
16. Baysal V, Yildirim M, Erel A, Kesici D. Is the combination of calcipotriol and PUVA effective in vitiligo? J Eur Acad Dermatol Venereol 2003; 17: 299-302.
17. Tjioe M, Gerritsen MJ, Juhlin L, van de Kerkhof PC. Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol 2002; 82: 369-372.
18. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42: 245-253.
19. Dogra S, Parsad D. Combination of narrowband UV-B and topical calcipotriene in vitiligo. Arch Dermatol 2003; 139: 393-232.